Back
ZyVersa Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
ZVSA
ZyVersa Therapeutics
Last Price:
$0.54
Seasonality Move:
-26.67%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVSA is experiencing slight buying pressure.
ZyVersa Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.63 | Sell |
20-day SMA: | 0.65 | Sell |
50-day SMA: | 0.62 | Sell |
200-day SMA: | 1.12 | Sell |
8-day EMA: | 0.46 | Buy |
20-day EMA: | 0.27 | Buy |
50-day EMA: | 0.13 | Buy |
200-day EMA: | 0.04 | Buy |
ZyVersa Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 40.83 | Sell |
Chaikin Money Flow: | 217385 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.71) | Sell |
Bollinger Bands (100): | (0.54 - 0.9) | Sell |
ZyVersa Therapeutics Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.55 while ZVSA 8-day simple moving average is 0.63, which is a Sell signal.
-
The stock price of ZVSA is 0.55 while ZyVersa Therapeutics 20-day SMA is 0.65, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 0.62 while ZVSA share price is 0.55, making it a Sell technically.
-
ZVSA stock price is 0.55 and ZyVersa Therapeutics 200-day simple moving average is 1.12, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
6
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.55. The Score for ZVSA is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
2.7M
Price in USD:
0.55
Share Volume:
465.8K
ZyVersa Therapeutics 52-Week Range
52-Week High:
5.30
52-Week Low:
0.47
Sell
6
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.55 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.55 while ZVSA 8-day exponential moving average is 0.46, which is a Buy signal.
-
The stock price of ZVSA is 0.55 while ZyVersa Therapeutics 20-day EMA is 0.27, which makes it a Buy.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.13 while ZVSA share price is 0.55, making it a Buy technically.
-
ZVSA stock price is 0.55 and ZyVersa Therapeutics 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting ZyVersa Therapeutics is a Buy
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 40.83, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.61 - 0.71), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.54 - 0.9), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.